Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

The Twin Cities metro is home to some of the strongest and largest medical technology and device companies in the nation, ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

Added to this, unfavorable currency movements are once again likely to have acted as a major dampener during the fiscal ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.

StarFish Medical, a leading North American full-service medical device development company, announced that it has acquired Omnica Corporation, a Southern California powerhouse in medical device design ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.

Freudenberg Medical is a global contract design and manufacturing partner to the medical device and biopharma industry with operations in Medtech hubs across the US, Europe, Asia and Costa Rica. The ...